Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
GlaxoSmithKline ( (GB:GSK) ) just unveiled an announcement.
GSK has repurchased 1,671,851 ordinary shares between 11 and 15 May 2026 under its ongoing share buyback programme, with the shares to be held in treasury. Following these transactions, GSK now holds 263,050,137 shares in treasury, representing 6.49% of voting rights, and has 4,053,167,539 ordinary shares in issue, clarifying the voting rights denominator for shareholders under UK disclosure rules.
The move underscores GSK’s continued use of buybacks as a capital management tool, potentially signalling confidence in its valuation and providing incremental support to earnings per share. The updated voting rights figure also has implications for institutional and other investors monitoring their holdings against regulatory disclosure thresholds in the UK market.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £21.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GSK Stock
According to Spark, TipRanks’ AI Analyst, GSK is a Neutral.
The score is driven primarily by solid underlying financial performance (strong margins and improved earnings) and supportive valuation (low P/E with a ~3.47% yield). These positives are partially offset by weak technical momentum (below key moving averages with negative MACD) and financial risk factors including meaningful leverage and uneven free-cash-flow consistency.
To see Spark’s full report on GSK stock, click here.
More about GlaxoSmithKline
GSK is a global biopharmaceutical company focused on developing and commercialising medicines and vaccines, using science and technology to prevent and treat disease. The company operates across major healthcare markets worldwide, targeting infectious diseases, respiratory conditions and other therapeutic areas through its research-driven portfolio.
Average Trading Volume: 7,819,554
Technical Sentiment Signal: Buy
Current Market Cap: £74.35B
See more data about GSK stock on TipRanks’ Stock Analysis page.